What Is Osteonecrosis Of The Jaw Symptoms Treatment?

Osteonecrosis of the jaw (ONJ) is a rare but serious condition where bone tissue in the jaw fails to heal after minor injury, leaving areas of exposed bone that do not heal within eight weeks. It most commonly occurs in people taking certain medications for osteoporosis or cancer, particularly bisphosphonates and denosumab. Symptoms include pain, swelling, loose teeth, and visible exposed bone in the mouth, while treatment focuses on controlling infection, managing pain, and supporting the body’s natural healing process rather than aggressive surgery.

What Causes Osteonecrosis of the Jaw?

The jawbone is unique in the body. It has a high rate of cell turnover and receives a large amount of blood flow. This makes it especially vulnerable when normal bone remodeling is disrupted.

Most cases of ONJ are linked to medications that slow bone turnover. These drugs are called antiresorptive agents. They include bisphosphonates like alendronate (Fosamax) and zoledronic acid (Reclast), as well as denosumab (Prolia, Xgeva). These medications are effective at preventing fractures in people with osteoporosis and managing bone complications in cancer patients.

In rare cases, the jawbone cannot repair itself after a small trauma, such as a tooth extraction or ill-fitting dentures. The bone loses its blood supply and dies. The overlying gum tissue breaks down, leaving the bone exposed to the mouth’s bacteria.

Another class of drugs called RANKL inhibitors works similarly. The risk of developing ONJ is higher in cancer patients receiving high-dose intravenous bisphosphonates than in people taking oral bisphosphonates for osteoporosis.

What Are the Symptoms of Osteonecrosis of the Jaw?

Symptoms can develop gradually. Early on, a person may notice no symptoms at all. The condition is often found during a routine dental examination.

When symptoms do appear, they typically include:

• Exposed bone in the mouth that does not heal
• Pain, swelling, or redness in the gum tissue
• Loose teeth
• Drainage or pus from the affected area
• Numbness or a heavy feeling in the jaw
• Bad breath that does not resolve with brushing

Some people experience pain that radiates to the ear or face. Others report difficulty eating because food becomes trapped in the exposed area.

The condition can range from mild to severe. The American Association of Oral and Maxillofacial Surgeons defines stages of ONJ based on the presence of exposed bone, pain, and infection. Stage 0 has no exposed bone but shows nonspecific symptoms. Stage 1 has exposed bone without pain or infection. Stage 2 has exposed bone with pain and infection. Stage 3 is the most severe, involving extensive bone damage that may extend beyond the jaw.

What Is Osteonecrosis Of The Jaw Symptoms Treatment?

Treatment depends on the stage of the condition and the underlying reason the person is taking the medication. The first step is always a complete evaluation by a dentist or oral surgeon who understands medication-related ONJ.

For early stages, conservative care is the standard approach. This includes:

• Antibacterial mouth rinses such as chlorhexidine
• Oral antibiotics to control infection
• Pain management with over-the-counter or prescription medications
• Gentle dental cleaning to keep the area free of debris

Surgical removal of dead bone is reserved for advanced cases that do not respond to conservative treatment. The goal of surgery is to remove only the dead bone and preserve as much healthy bone as possible.

In some cases, doctors may recommend a drug holiday. This means pausing the bisphosphonate or denosumab for a period of time. Evidence for this practice is limited. The decision is made case by case, weighing the risk of fractures against the risk of ONJ progression. Never stop these medications without talking to your prescribing doctor.

Hyperbaric oxygen therapy has been used in some centers. It delivers high concentrations of oxygen to the tissues under pressure. Some studies suggest it may improve healing, but large clinical trials have not confirmed a clear benefit. It is not considered standard first-line therapy.

Who Is at Risk for Osteonecrosis of the Jaw?

Risk increases with the dose and duration of antiresorptive medication. People receiving intravenous zoledronic acid every month for cancer treatment face a higher risk than people taking a weekly oral pill for osteoporosis.

Dental procedures are the most common trigger. Tooth extractions, dental implants, and periodontal surgery all create small wounds in the jawbone. If the bone cannot remodel and heal, ONJ can develop at the site.

Other risk factors include:

• Poor oral hygiene
• Denture use that causes pressure on the gums
• Diabetes
• Smoking
• Obesity
• Corticosteroid use
• Rheumatoid arthritis

The overall risk for people with osteoporosis taking oral bisphosphonates is low. Estimates suggest it occurs in fewer than 1 in 1,000 people per year. The risk for cancer patients on high-dose intravenous therapy is higher, but still uncommon.

How Is Osteonecrosis of the Jaw Prevented?

Prevention starts before treatment with antiresorptive medications begins. The American Dental Association and other professional groups recommend that people complete any needed dental work before starting bisphosphonates or denosumab.

If dental work is needed while on these medications, the dentist should use the least invasive approach possible. Root canals are preferred over extractions when feasible. If an extraction is unavoidable, the socket should be smoothed and closed with sutures to promote healing.

Regular dental checkups are essential. A dentist can spot early signs of ONJ before symptoms become severe. Good oral hygiene at home, including brushing and flossing, reduces the bacterial load in the mouth and lowers the risk of infection.

For people already diagnosed with ONJ, avoiding further trauma to the area is critical. Dentures may need to be adjusted or discontinued. Dental implants should not be placed in an area with active ONJ.

How Long Does Osteonecrosis of the Jaw Take to Heal?

Healing time varies widely. Some people with mild ONJ improve within a few weeks of conservative treatment. Others experience symptoms for months or years.

The condition can become chronic. Even with successful treatment, the exposed bone may take a long time to fully re-cover with gum tissue. In some cases, small areas of exposed bone remain but become painless and stable. This is considered a controlled state rather than a cure.

Research on outcomes shows that most people with medication-related ONJ improve with nonsurgical care. Complete resolution is more likely in people with early-stage disease and no active infection.

When to See a Doctor or Dentist

Anyone taking bisphosphonates or denosumab who notices exposed bone, persistent pain, swelling, or loose teeth should see a dentist right away. Early evaluation improves the chances of successful treatment.

People who have not taken these medications but develop similar symptoms should also seek care. ONJ can occasionally occur without any medication exposure, although this is extremely rare. Other conditions can mimic ONJ, including severe periodontal disease, bone infections, and oral cancer. A proper diagnosis requires clinical examination and often imaging such as dental X-rays or a CT scan.

Biopsy is sometimes needed to rule out other conditions. This is done carefully because biopsy itself can worsen ONJ in people taking antiresorptive medications.

Can Osteonecrosis of the Jaw Be Reversed?

There is no medication that reverses ONJ once it develops. The body can heal the area, but the process is slow and not guaranteed.

Research is exploring treatments such as low-level laser therapy and bone morphogenetic proteins, but these remain experimental. No large human trials have confirmed their effectiveness.

The most honest answer is that ONJ is manageable but not always curable. Many people live with stable, painless areas of exposed bone for long periods. Others require ongoing courses of antibiotics to control recurrent infections.